Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Limited]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lgh发布了新的文献求助10
1秒前
2秒前
3秒前
火山世界树完成签到,获得积分20
3秒前
滕遥完成签到,获得积分10
4秒前
瓦力文发布了新的文献求助10
5秒前
ertredffg完成签到,获得积分10
6秒前
糖糖爱干饭完成签到 ,获得积分10
6秒前
精明尔柳完成签到,获得积分10
6秒前
严笑容发布了新的文献求助10
7秒前
Gaojie Yan完成签到,获得积分10
8秒前
8秒前
发财小鱼完成签到 ,获得积分10
9秒前
xjp完成签到,获得积分10
9秒前
科研通AI2S应助kzg采纳,获得10
9秒前
fabulous完成签到,获得积分10
10秒前
脑洞疼应助科研通管家采纳,获得10
10秒前
CipherSage应助科研通管家采纳,获得10
10秒前
王宇杰完成签到,获得积分10
10秒前
斯文败类应助科研通管家采纳,获得10
10秒前
NexusExplorer应助科研通管家采纳,获得10
10秒前
科研通AI2S应助科研通管家采纳,获得10
10秒前
10秒前
Gilana应助科研通管家采纳,获得10
11秒前
思源应助科研通管家采纳,获得10
11秒前
科研通AI2S应助科研通管家采纳,获得10
11秒前
Akim应助科研通管家采纳,获得10
11秒前
可耐的妙海完成签到 ,获得积分10
11秒前
xyzdmmm完成签到,获得积分10
12秒前
常葶完成签到,获得积分10
13秒前
mofei完成签到,获得积分20
13秒前
张ZC发布了新的文献求助10
15秒前
小北完成签到,获得积分10
15秒前
芋圆完成签到,获得积分10
15秒前
梓ccc完成签到,获得积分10
16秒前
真实的麦片完成签到,获得积分10
16秒前
16秒前
dh完成签到,获得积分10
16秒前
王梓磬完成签到,获得积分10
17秒前
18秒前
高分求助中
Evolution 3rd edition 1500
Lire en communiste 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
2-Acetyl-1-pyrroline: an important aroma component of cooked rice 500
Ribozymes and aptamers in the RNA world, and in synthetic biology 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3180066
求助须知:如何正确求助?哪些是违规求助? 2830409
关于积分的说明 7977031
捐赠科研通 2491999
什么是DOI,文献DOI怎么找? 1329172
科研通“疑难数据库(出版商)”最低求助积分说明 635669
版权声明 602954